已收盘 02-06 16:00:00 美东时间
+0.210
+5.34%
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index fa...
2025-11-04 03:23
Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today that it has entered
2024-09-16 19:08